期刊文献+

厄贝沙坦对血管生成素样蛋白2在糖尿病大鼠肾脏表达的影响 被引量:7

The effect of irbesartan on the expression of angiopoietin-like protein 2 in the kidneys of type 2 diabetes rats
原文传递
导出
摘要 目的通过观察厄贝沙坦对糖尿病大鼠血管生成素样蛋白2(ANGPTL2)表达的影响,探讨其主要的作用机制。方法60只雄性SD大鼠随机分为正常对照组(NC,15只)和实验组(45只)。实验组予高糖高脂喂养联合小剂量链脲菌素(STZ,30mg/kg)建立2型糖尿病(T2DM)大鼠模型,成功的模型(36只)再随机分为2组:糖尿病组(DM,18只)及厄贝沙坦组(DI,18只)。分别检测4周、8周及12周测体质量、血压、肾质量、血糖、血肌酐(Scr)、尿素氮(BUN),24h尿蛋白(UAL)的排泄量,镜下观察肾组织病理改变,免疫组化染色技术、实时定量PCR及Western印迹法检测肾组织ANGPTL2 mRNA及蛋白表达。结果DM组24h尿白蛋白量、三酰甘油、胆固醇、BUN及Scr在4周、8周及12周逐渐升高,且均高于同时间的NC组,差异有统计学意义(均P<0.05)。DI组以上述指标均低于同时间的DM组,差异有统计学意义(均P<0.05)。DM组4周、8周及12周的肾脏病理改变逐渐加重,同时间的DI组肾脏病理改变较DM组轻,但仍重于NC组。DM组4周、8周及12周肾脏中的ANGPTL2mRNA及蛋白的表达较NC组明显升高(均P<0.05),DI组ANGPTL2的表达量低于同一时间的DM组,差异有统计学意义(P<0.05)。结论ANGPTL2在糖尿病大鼠肾脏的表达量逐渐升高,而厄贝沙坦可降低ANGPTL2在肾的表达,保肾脏。 Objective To observe the effect of irbesartan on the expression of angiopoietinlike protein 2 (ANGPTL2) in the diabetic rats kidney and explore the underlying mechanism. Methods A total of sixty male SD rats were divided into normal control group (NC group, n=15) and experimental group (n=45) randomly. The experimental group was fed with high sugar-fat diet and given a low dose streptozoein (STZ 30 mg/kg)to establish type 2 diabetic model. Rats successfully induced diabetes were randomly divided into 2 groups: diabetes group (DM) and irbesartan group (DI). Weight, blood pressure, blood glucose, serum creatinine (Scr), blood urea nitrogen(BUN), 24 hour urinary albumin(UAL) and renal histomorphology were observed after drug intervention at the 4^th, 8th and 12^th weeks. The expression of ANGPTL2 in renal tissue were detected by immunohistochemistry, real-time PCR and Western blotting. Results The levels of Scr, BUN, TG, TC and UAL in group DM were higher than in group NC at the 4^th, 8^th and 12^th week (all P〈 0.05). Compared with that in group DM,above indexes were lower in group DI at the 4^th, 8^th and 12^th week (all P〈0.05). The pathological changes of the kidney in group DM were more serious than that in group DI. The expression of ANGPTL2 in group DM was much higher than that in group NC at the 4^th, 8^th and 12^th week (all P〈0.05), and irbesartan treatment inhibited the up-regulation of ANGPTL2 in group DI(all P 〈0.05). Conclusion The expression of ANGPTL2 increases in T2DM rats kidney tissue with time and irbesartan can inhibit the up-regulation of ANGPTL2 in T2DM rats.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2014年第8期609-613,共5页 Chinese Journal of Nephrology
基金 青岛市科技局课题(2012-1-3-1-19-nsh)
关键词 糖尿病 肾病 血管生成素样蛋白2 厄贝沙坦 Diabetic nephropathy Angiopoietin-like protein 2 Irbesartan
  • 相关文献

参考文献4

二级参考文献73

  • 1吴义超,刘志红,曾彩虹,苏健,陈朝红,黎磊石.糖尿病肾病患者肾小球基因表达谱及其与病情进展的关系[J].肾脏病与透析肾移植杂志,2004,13(6):503-511. 被引量:14
  • 2陈建康,邹万忠,由江峰.内皮素与肾小球系膜细胞的关系[J].中华病理学杂志,1996,25(4):206-208. 被引量:26
  • 3王金泉,刘志红.终末期糖尿病肾病肾替代治疗[J].医学研究生学报,2006,19(7):664-668. 被引量:20
  • 4Dedov II,Shestakov MV,Kochemasova TV,et al.Endothelial dysfunction in the development of vascular complications in diabetes mellitas.Ross Fiziol Zh Im I M Sechenova,2001,87(8):1073-1084.
  • 5Joussen AM,Poulaki V,Tsujikawa A,e tal.Suppression of diabetic retinopathy with angiopoietin-1.Am J Pathol.2002,160 (5):1683-1693.
  • 6Pizurki L,Zhou Z,Glynos K,et al.Angiopoietin-1 inhibits endothelial permeability,neutrophil adherence and IL-8 production.Br J Pharmacol,2003,139(2):329-336.
  • 7Yamamoto Y,Maeshima Y,Kitayama H,et al.Tumstatin peptide,an inhibitor of angiogenesis,prevents glomerular hypertrophy in the early stage of diabetic nephropathy.Diabetes,2004,53 (7):1831-1840.
  • 8Abrass CK.Cellular lipid metabolism and the role of lipids in progressive renal disease.Am J Nepbrol,2004,24(1):46-53.
  • 9Constantinescu E,Alexandru D,Alexandru V,et al.Endothelial cell-derived foam cells fail to express adhesion molecules (ICAM-1and VCAM-1) for monocytes.J Submicrosc Cytol Pathol,2000,32(2):195-201.
  • 10Lorenzi M,Cagliero E.Pathobiology of endothelial and other vascular cells in diabetes mellitus.Call for data.Diabetes,1991,40 (6):653-659.

共引文献20

同被引文献56

  • 1张萍.灯盏花素联合氯沙坦治疗糖尿病肾病的临床观察[J].中国药房,2006,17(18):1403-1404. 被引量:13
  • 2张满生,朱晓玲,王永钧.灯盏花注射液对ET-1诱导的大鼠系膜细胞增殖的影响[J].中国中西医结合肾病杂志,2005,6(11):626-628. 被引量:15
  • 3龙海波,钟娟,魏连波,周伟东,许兆忠.厄贝沙坦对早期糖尿病肾病大鼠足细胞nephrin表达的影响[J].中国病理生理杂志,2007,23(6):1176-1180. 被引量:7
  • 4中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:54-58.
  • 5Lewis EJ,Hunsicker LG,Clarke WR,et al.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes[J].N Engl J Med,2001,345(12):851-860.
  • 6Han SY,Kang YS,Jee YH,et al.High glucose and angiotensin II increase beta1 integrin and integrin-linked kinase synthesis in cultured mouse podocytes[J].Cell Tissue Res,2006,323(2):321-332.
  • 7Kandasamy N,Ashokkumar N.Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy[J].Eur J Pharmacol,2014;15(743):53-62.
  • 8Parvizi MR,Parviz M,Tavangar SM,et al.Protective effect of magnesium on renal function in STZ-induced diabetic rats[J].J Diabetes Metab Disord,2014;13(1):84-5.
  • 9Peng T,Wang J,Zhen J,et al.Effect of benazepril on the transdifferentiation of renal tubular epithelial cells from diabetic rats[J].Biomed Rep,2014;2(4):490-4.
  • 10Hartner A,Cordasic N,Klanke B,et al.Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation,not of endoplasmic reticulum stress[J].Biochim Biophys Acta,2014;1842(4):558-65.

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部